The stock of Intec Pharma LTD. – Ordinary Shares (NASDAQ:NTEC) registered a decrease of 7.91% in short interest. NTEC’s total short interest was 689,500 shares in March as published by FINRA. Its down 7.91% from 748,700 shares, reported previously. With 109,700 shares average volume, it will take short sellers 6 days to cover their NTEC’s short positions.
The stock decreased 0.80% or $0.06 during the last trading session, reaching $7.4. About 249,371 shares traded. Intec Pharma Ltd. (NASDAQ:NTEC) has risen 34.75% since March 10, 2018 and is uptrending. It has outperformed by 30.38% the SP500.
Intec Pharma Ltd., a clinical stage biopharmaceutical company, focuses on developing drugs based on its proprietary Accordion Pill platform technology in Israel. The company has market cap of $245.92 million. The Company’s Accordion Pill is